1. Home
  2. CVKD vs HHS Comparison

CVKD vs HHS Comparison

Compare CVKD & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • HHS
  • Stock Information
  • Founded
  • CVKD 2022
  • HHS 1923
  • Country
  • CVKD United States
  • HHS United States
  • Employees
  • CVKD N/A
  • HHS N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • HHS Advertising
  • Sector
  • CVKD Health Care
  • HHS Consumer Discretionary
  • Exchange
  • CVKD Nasdaq
  • HHS Nasdaq
  • Market Cap
  • CVKD 29.5M
  • HHS 30.3M
  • IPO Year
  • CVKD 2023
  • HHS N/A
  • Fundamental
  • Price
  • CVKD $12.68
  • HHS $3.75
  • Analyst Decision
  • CVKD Strong Buy
  • HHS
  • Analyst Count
  • CVKD 1
  • HHS 0
  • Target Price
  • CVKD $32.00
  • HHS N/A
  • AVG Volume (30 Days)
  • CVKD 33.5K
  • HHS 31.5K
  • Earning Date
  • CVKD 08-06-2025
  • HHS 08-07-2025
  • Dividend Yield
  • CVKD N/A
  • HHS N/A
  • EPS Growth
  • CVKD N/A
  • HHS N/A
  • EPS
  • CVKD N/A
  • HHS N/A
  • Revenue
  • CVKD N/A
  • HHS $181,355,000.00
  • Revenue This Year
  • CVKD N/A
  • HHS $6.54
  • Revenue Next Year
  • CVKD N/A
  • HHS N/A
  • P/E Ratio
  • CVKD N/A
  • HHS N/A
  • Revenue Growth
  • CVKD N/A
  • HHS N/A
  • 52 Week Low
  • CVKD $5.70
  • HHS $3.24
  • 52 Week High
  • CVKD $22.90
  • HHS $8.85
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 47.47
  • HHS 40.02
  • Support Level
  • CVKD $11.00
  • HHS $3.24
  • Resistance Level
  • CVKD $13.24
  • HHS $4.35
  • Average True Range (ATR)
  • CVKD 1.13
  • HHS 0.54
  • MACD
  • CVKD 0.20
  • HHS 0.00
  • Stochastic Oscillator
  • CVKD 72.33
  • HHS 23.72

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

About HHS Harte-Hanks Inc.

Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.

Share on Social Networks: